Keysight Technologies enters September with a familiar tension: the Street raised targets sharply after August earnings, yet the stock is still trading nearly 25% below the analyst consensus.
That gap deserves scrutiny. Following a Q3 beat and guidance raise on August 18, at least eight firms lifted their price targets on the same day — JP Morgan and Morgan Stanley both moving to $425, UBS and Susquehanna to $440, Barclays to $429. The direction of travel is uniform: every firm that acted maintained or held a positive rating, and not one cut. The consensus mean now sits at $415, against a close of $327. That's a 27% implied return from the current price, which is either a compelling opportunity or a signal that the stock's August earnings drop — it fell 11.5% the day results landed and shed a further 11.4% over the following week — has reset the market's near-term view of the name. Analyst sentiment ranks in the 92nd percentile on ORTEX's factor scoring, reflecting just how lopsided the bullish skew has become.
Positioning, however, tells a story of calm rather than conviction. Short interest is a modest 1.7% of the free float, down about 3.5% over the past month. Cost to borrow is near its lowest level of the summer at 0.38%, easing a further 8% on the week. Borrow availability is essentially unlimited — the lending pool is as open as it has been all year. That rules out any meaningful short-squeeze dynamic, but it also means there is no technical pressure building against the shorts. Options positioning has nudged slightly more defensive: the put/call ratio moved to 0.69, nearly two standard deviations above its 20-day average of 0.65. That's not alarming, but it marks the most protective skew the options market has put on the stock since the earnings reaction, sitting just off the lowest PCR reading of the past year. The move is small and may simply reflect traders buying downside protection while the stock consolidates after the post-earnings drop.
The earnings history on this name is worth carrying forward. The August print produced a single-day move of negative 11.5% despite a beat and raised guidance — a reminder that the market's reaction function for Keysight is not always intuitive. The next event is flagged for late November. Between now and then, valuation multiples give some context: the trailing P/E has eased to 25.2x and EV/EBITDA to 21.1x, both down meaningfully over 30 days as the stock pulled back. Price-to-book remains firm at 7.0x. On the factor side, 30-day EPS momentum ranks in the 90th percentile — the forward estimate revision cycle is clearly positive — but 12-month forward EPS growth scores just 21st percentile, pointing to a valuation where near-term momentum is strong but longer-duration growth expectations are more modest.
On the ownership side, one notable move from the 13D/G register: T. Rowe Price disclosed a reduction from 8.7% to 5.6% of class in its most recent filing dated August 14 — a material trim from one of the historically larger active holders. BlackRock reported adding over 1.4 million shares in its latest institutional filing, reinforcing the other end of the ledger. Insider flow is net negative over 90 days, with roughly $3.5 million in net selling. Director NYE JEAN MCCLUNG sold 3,000 shares at $319 on August 21 — a discretionary sale, no 10b5-1 plan. SVP Ingrid Estrada's two recent sales totaling 4,000 shares were both under a pre-arranged plan and carry less interpretive weight.
Close correlated peers — AEIS, JBL, and TTMI — all posted gains of 3-6% on the week, broadly in line with KEYS's 2.3% weekly move. The sector is recovering. What to watch in the weeks ahead is whether the stock can begin to close its gap to analyst targets, or whether the severity of the August earnings reaction continues to weigh on sentiment into the November print.
See the live data behind this article on ORTEX.
Open KEYS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.